First patient receives treatment in trial of ‘resistance-busting’ skin cancer drug

The Royal Marsden NHS Foundation Trust in London is conducting the skin cancer clinical trial

This is a free article for registered users

This article is not available as part of an institutional subscription. Why is this? You can register for free access.